219 related articles for article (PubMed ID: 7902566)
21. c-erbA: protooncogene or growth suppressor gene?
Damm K
Adv Cancer Res; 1992; 59():89-113. PubMed ID: 1355627
[No Abstract] [Full Text] [Related]
22. ErbA: tumor suppressor turned oncogene?
Damm K
FASEB J; 1993 Jul; 7(10):904-9. PubMed ID: 8102105
[TBL] [Abstract][Full Text] [Related]
23. Requirements for repression of retinoid X receptor by the oncoprotein P75gag-v-erbA and the thyroid hormone receptors.
Wahlström GM; Vennström B
Mol Endocrinol; 1998 May; 12(5):645-53. PubMed ID: 9605927
[TBL] [Abstract][Full Text] [Related]
24. Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo.
Ciana P; Braliou GG; Demay FG; von Lindern M; Barettino D; Beug H; Stunnenberg HG
EMBO J; 1998 Dec; 17(24):7382-94. PubMed ID: 9857194
[TBL] [Abstract][Full Text] [Related]
25. A novel mechanism of action for v-ErbA: abrogation of the inactivation of transcription factor AP-1 by retinoic acid and thyroid hormone receptors.
Desbois C; Aubert D; Legrand C; Pain B; Samarut J
Cell; 1991 Nov; 67(4):731-40. PubMed ID: 1682056
[TBL] [Abstract][Full Text] [Related]
26. The v-erbA oncogene requires cooperation with tyrosine kinases to arrest erythroid differentiation induced by ligand-activated endogenous c-erbA and retinoic acid receptor.
Schroeder C; Gibson L; Beug H
Oncogene; 1992 Feb; 7(2):203-16. PubMed ID: 1347913
[TBL] [Abstract][Full Text] [Related]
27. Identification of DNA binding sites for the V-erbA oncoprotein, the viral homolog to thyroid hormone receptor alpha.
Harbers M; Wahlström GM; Vennström B
J Steroid Biochem Mol Biol; 1998 Nov; 67(3):181-91. PubMed ID: 9879977
[TBL] [Abstract][Full Text] [Related]
28. Kindred S thyroid hormone receptor is an active and constitutive silencer and a repressor for thyroid hormone and retinoic acid responses.
Baniahmad A; Tsai SY; O'Malley BW; Tsai MJ
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10633-7. PubMed ID: 1359543
[TBL] [Abstract][Full Text] [Related]
29. Constitutive transactivation by the thyroid hormone receptor and a novel pattern of activity of its oncogenic homolog v-ErbA in Xenopus oocytes.
Nagl SB; Nelson CC; Romaniuk PJ; Allison LA
Mol Endocrinol; 1995 Nov; 9(11):1522-32. PubMed ID: 8584030
[TBL] [Abstract][Full Text] [Related]
30. V-erbA and c-erbA proteins enhance transcriptional activation by c-jun.
Sharif M; Privalsky ML
Oncogene; 1992 May; 7(5):953-60. PubMed ID: 1349165
[TBL] [Abstract][Full Text] [Related]
31. v-erb A, nuclear hormone receptors, and oncogenesis.
Privalsky ML
Biochim Biophys Acta; 1992 Sep; 1114(1):51-62. PubMed ID: 1356442
[No Abstract] [Full Text] [Related]
32. Transcriptional repression of band 3 and CAII in v-erbA transformed erythroblasts accounts for an important part of the leukaemic phenotype.
Fuerstenberg S; Leitner I; Schroeder C; Schwarz H; Vennström B; Beug H
EMBO J; 1992 Sep; 11(9):3355-65. PubMed ID: 1354613
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of transformation by v-ErbA: substitution for steroid hormone receptor function in self renewal induction.
Bauer A; Ulrich E; Andersson M; Beug H; von Lindern M
Oncogene; 1997 Aug; 15(6):701-15. PubMed ID: 9264411
[TBL] [Abstract][Full Text] [Related]
34. At least three subdomains of v-erbA are involved in its silencing function.
Busch K; Martin B; Baniahmad A; Renkawitz R; Muller M
Mol Endocrinol; 1997 Mar; 11(3):379-89. PubMed ID: 9058383
[TBL] [Abstract][Full Text] [Related]
35. Functional domains of the v-erbA protein necessary for oncogenesis are required for transcriptional activation in Saccharomyces cerevisiae.
Smit-McBride Z; Privalsky ML
Oncogene; 1993 Jun; 8(6):1465-75. PubMed ID: 8099219
[TBL] [Abstract][Full Text] [Related]
36. Isolation of a cDNA encoding human Rev-ErbA alpha: transcription from the noncoding DNA strand of a thyroid hormone receptor gene results in a related protein that does not bind thyroid hormone.
Lazar MA; Jones KE; Chin WW
DNA Cell Biol; 1990 Mar; 9(2):77-83. PubMed ID: 1971514
[TBL] [Abstract][Full Text] [Related]
37. Roles of v-erbA homodimers and heterodimers in mediating dominant negative activity by v-erbA.
Yen PM; Ikeda M; Brubaker JH; Forgione M; Sugawara A; Chin WW
J Biol Chem; 1994 Jan; 269(2):903-9. PubMed ID: 7904604
[TBL] [Abstract][Full Text] [Related]
38. Functional interaction between the two zinc finger domains of the v-erb A oncoprotein.
Hall BL; Bonde BG; Judelson C; Privalsky ML
Cell Growth Differ; 1992 Apr; 3(4):207-16. PubMed ID: 1355356
[TBL] [Abstract][Full Text] [Related]
39. Functional inhibition of retinoic acid response by dominant negative retinoic acid receptor mutants.
Damm K; Heyman RA; Umesono K; Evans RM
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2989-93. PubMed ID: 8096643
[TBL] [Abstract][Full Text] [Related]
40. Biological effects of the v-erbA oncogene in transformation of avian erythroid cells.
Vennström B; Beug R; Damm K; Engel D; Gehring U; Graf T; Muñoz A; Sap J; Zenke M
Horm Metab Res Suppl; 1987; 17():14-9. PubMed ID: 2895057
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
